Simvastatin in phase III

A forum to discuss research on the origins of MS and its development.
Post Reply
User avatar
frodo
Family Elder
Posts: 1641
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Simvastatin in phase III

Post by frodo »

Simvastatin starting a phase III trial. This is important because it is not an immune modulator. It is a cholesterol lowering drug and if it works, it will open new research paths about MS pathogenesis.

https://www.mssociety.org.uk/research/l ... ecruitment

MS-STAT2 is investigating whether cholesterol-lowering drug simvastatin slows disability progression in secondary progressive MS. It’s a phase 3 trial. So it’s the final, definitive stage of testing following positive smaller trials.

With recruitment finishing, we’re a step closer to knowing whether simvastatin could be the first treatment for people with progressive MS that protects nerves from damage in MS.
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “MS Etiology and Pathogenesis”